Holmium:yttrium-aluminum-garnet laser prostatectomy

Area of Science:

• Urology
• Minimally Invasive Surgery
• Laser Technology

Background:

• Benign prostatic hyperplasia (BPH) is commonly treated with transurethral resection of the prostate (TURP).
• Laser prostatectomy, including neodymium:YAG and potassium titanyl phosphate (KTP) lasers, offers reduced morbidity compared to TURP.
• Disadvantages of earlier laser methods include prolonged catheterization and delayed symptom relief.

Purpose of the Study:

• To evaluate the holmium:YAG laser as an alternative treatment for BPH.
• To assess the safety and efficacy of holmium laser prostatectomy.
• To compare holmium laser procedures with existing BPH treatments.

Main Methods:

• Investigation of holmium:YAG laser properties, including high absorption by tissue water and rapid vaporization.
• Pre-clinical studies in canine prostates and human prostatectomy specimens.
• Clinical trials evaluating holmium:YAG laser prostatectomy and transurethral incision of the prostate.

Main Results:

• Holmium:YAG laser prostatectomy demonstrated no significant fluid absorption or blood loss.
• Complications were minimal, and immediate improvement in voiding outcomes was observed.
• Transurethral incision of the prostate using the holmium laser was rapid and hemostatic.

Conclusions:

• Holmium laser resection of the prostate is a safe and effective procedure for relieving symptomatic bladder outlet obstruction due to BPH.
• The holmium:YAG laser provides immediate voiding improvement with reduced morbidity.
• This technique represents a significant advancement in BPH management.